What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study. [electronic resource]
- PloS one 2020
- e0227128 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0227128 doi
Aged Antiparkinson Agents--adverse effects Antipsychotic Agents--therapeutic use Disruptive, Impulse Control, and Conduct Disorders--drug therapy Female Humans Iatrogenic Disease--epidemiology Indoles--adverse effects Male Middle Aged Parkinson Disease--drug therapy Pramipexole--adverse effects Selective Serotonin Reuptake Inhibitors--therapeutic use